For one ICU physician and startup CMO, the more immediate danger isn’t an autonomous system taking over medicine and leaving ...
The FDA is recruiting to fill vacancies on its advisory committees, informally known as adcomms. While these committees have ...
Jimini Health has raised $17 million in seed funding to help behavioral health organizations safely deploy AI at scale, the company announced on Tuesday. The New York-based company is building ...
AstraZeneca’s equity investment in Summit Therapeutics comes with plans for clinical trial collaborations. The deal brings ...
Pelago launched a behavioral health platform that integrates substance use, mental health and behavioral addiction care, ...
Mirum Pharmaceuticals’ Atebrioz is the third FDA-approved drug for fibrodysplasia ossificans progressiva (FOP), but it brings ...
When drug prices are too high for patients, physicians take on additional workload to find solutions. A newly released 2026 ...
DreaMed Wins FDA Clearance for CGM-Driven Insulin Automation Tool for Both Type 2 Injection Regimens
DreaMed Diabetes has received FDA 510(K) clearance for MODI, a mobile app that uses CGM (continuous glucose monitoring) data ...
HHS Secretary Robert F. Kennedy Jr. named eight new members to the U.S. Preventive Services Task Force this week, completing ...
The next evolution in ADHD therapy needs to focus not only on drug efficacy but also on how treatment aligns with the ...
The question is whether these AI tools will be another fragmented layer of technology or true assistants to help them spend ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results